QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
OTCMKTS:HCYTD

H-CYTE (HCYTD) Stock Forecast, Price & News

$2.02
-1.98 (-49.50%)
(As of 07/11/2022)
Compare
Today's Range
$2.02
$2.77
50-Day Range
$2.02
$2.02
52-Week Range
$2.02
$77.00
Volume
400 shs
Average Volume
103 shs
Market Capitalization
$521,160.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HCYTD stock logo

About H-CYTE (OTCMKTS:HCYTD) Stock

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Receive HCYTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H-CYTE and its competitors with MarketBeat's FREE daily newsletter.

HCYTD Stock News Headlines

10-K: H-CYTE, INC.
BREAKING: The truth about war with China
Foreign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.
HCYT H-CYTE, Inc.
H-CYTE Completes Acquisition of Jantibody
H-CYTE Announces 1-for-1,000 Reverse Stock Split
BREAKING: The truth about war with China
Foreign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.
Should You Refrigerate Peanut Butter?
H-CYTE Inc (HCYT)
H-CYTE Names Michael Yurkowsky Chief Executive Officer
Scanfil plc: Managers' transactions – Jokitalo
Robert Greif named Chief Executive Officer of H-CYTE
See More Headlines
Receive HCYTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H-CYTE and its competitors with MarketBeat's FREE daily newsletter.

HCYTD Company Calendar

Today
5/18/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:HCYTD
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Net Income
$-4,800,000.00
Net Margins
-450.40%
Pretax Margin
-450.40%

Debt

Sales & Book Value

Annual Sales
$1.61 million
Book Value
($31.45) per share

Miscellaneous

Free Float
244,000
Market Cap
$521,160.00
Optionable
Not Optionable
Beta
1.12

Key Executives

  • Mr. Michael W. Yurkowsky (Age 50)
    CEO & Director
    Comp: $180k
  • Mr. Jeremy Daniel (Age 46)
    Chief Financial Officer
    Comp: $200k
  • Dr. Tanya Rhodes Ph.D. (Age 61)
    Chief Scientific Officer
    Comp: $252k
  • Mr. Jeffery Wright CPA (Age 39)
    CPA, Controller & Principal Accounting Officer













HCYTD Stock - Frequently Asked Questions

How have HCYTD shares performed in 2023?

H-CYTE's stock was trading at $2.02 on January 1st, 2023. Since then, HCYTD shares have increased by 0.0% and is now trading at $2.02.
View the best growth stocks for 2023 here
.

What is H-CYTE's stock symbol?

H-CYTE trades on the OTCMKTS under the ticker symbol "HCYTD."

How do I buy shares of H-CYTE?

Shares of HCYTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is H-CYTE's stock price today?

One share of HCYTD stock can currently be purchased for approximately $2.02.

How much money does H-CYTE make?

H-CYTE (OTCMKTS:HCYTD) has a market capitalization of $521,160.00 and generates $1.61 million in revenue each year.

How can I contact H-CYTE?

H-CYTE's mailing address is 201 E Kennedy Blvd Suite 700, Tampa FL, 33602. The official website for the company is www.hcyte.com. The company can be reached via phone at (844) 633-6839 or via email at jassad@hcyte.com.

This page (OTCMKTS:HCYTD) was last updated on 5/18/2023 by MarketBeat.com Staff

My Account -